Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
The Washington Tree Fruit Association says this is not surprising and notes the USDA has offered a lifeline to growers while they transition away from the cannery market.
October 29 – November 1, 2025
Large animal veterinarian Dr. Rosalyn Biggs with Oklahoma State University warns producers may not be prepared for the real threat of New World Screwworm.

LATEST STORIES BY THIS AUTHOR:

Livestock profits are propping up overall sentiment, but crop producers remain cautious amid tight margins and uncertain policy signals.
Farmers for Free Trade Executive Director Brian Kuehl shares more about the tour to gather farmers’ insights on the economic challenges they face in the ag economy.
Recent U.S.–China trade developments provided a small lift for soy markets, though most traders are waiting for concrete purchase data before making major moves.
Wheat futures briefly hit a three-month high before retreating as the markets wait for word on whether the deal will actually happen.
According to the new report, seven out of ten rural bankers support President Trump’s recent trade steps with China, expressing cautious optimism about future export potential.
Dr. Jeffrey Gold discusses ways families can approach changes in aging loved ones over the holiday season and manage care with compassion and empathy.